Akero Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Akero Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2020 to Q3 2024.
  • Akero Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -29.9 %, a 25.2% decline year-over-year.
  • Akero Therapeutics, Inc. annual Return On Assets for 2023 was -27.2 %, a 33.6% increase from 2022.
  • Akero Therapeutics, Inc. annual Return On Assets for 2022 was -41.1 %, a 6.83% increase from 2021.
  • Akero Therapeutics, Inc. annual Return On Assets for 2021 was -44.1 %, a 13.2% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -29.9 -6.01 -25.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -27.3 -0.86 -3.26% Apr 1, 2024 Jun 30, 2024
Q1 2024 -25.7 +9.52 +27% Jan 1, 2024 Mar 31, 2024
Q4 2023 -27.2 +13.8 +33.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -23.9 +28.3 +54.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -26.4 +30.5 +53.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -35.2 +18.8 +34.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -41.1 +3.01 +6.83% Oct 1, 2022 Dec 31, 2022
Q3 2022 -52.2 -12.7 -32% Jul 1, 2022 Sep 30, 2022
Q2 2022 -56.9 -21.3 -59.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -54 -19.2 -54.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -44.1 -5.15 -13.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -39.5 -1.16 -3.02% Jul 1, 2021 Sep 30, 2021
Q2 2021 -35.6 +9.21 +20.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -34.9 -0.09 -0.26% Jan 1, 2021 Mar 31, 2021
Q4 2020 -38.9 Oct 1, 2020 Dec 31, 2020
Q3 2020 -38.4 Jul 1, 2020 Sep 30, 2020
Q2 2020 -44.8 Apr 1, 2020 Jun 30, 2020
Q1 2020 -34.8 Jan 1, 2020 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.